Assura agrees £31m funding deal on cancer centre

1st Apr 2022 07:20

(Sharecast News) - Primary care property investor Assura said it had agreed development funding agreement for a £31m cancer diagnostic and treatment centre in Guildford.

The building will be operated by and let to Genesis Cancer Care UK Limited on a 30-year FRI lease with annual, index-linked rent reviews.

Adjacent to the Royal Surrey County Hospital, the centre will provide oncology and cancer care services via a partnership agreement between GenesisCare and the Royal Surrey NHS Foundation Trust, Assura said.

Top Risers

Share	Price	Change
Faron Pharma (FARN)	197.50	27.42%
Katoro Gold (KAT)	0.10	25%
S4 Cap. (SFOR)	54.50	17.86%
Aptamer Group (APTA)	0.725	17.74%
polarean (POLX)	4.05	17.39%

Top Fallers

Share	Price	Change
Genedrive (GDR)	2.25	-35.71%
Argo Group (ARGO)	4.00	-27.27%
Mothercare (MTC)	5.00	-19.35%
Ultimate Prod (ULTP)	143.00	-15.88%
Landore (LND)	2.775	-14.62%

Top By Volume

Share	Price	Volume
Supply@me Cap (SYME)	0.023	449,232,198
Tower Resources (TRP)	0.019	309,723,816
Baron Oil (BOIL)	0.07	297,058,158
Premier African Minerals (PREM)	0.205	283,523,193
Tertiary Minerals (TYM)	0.125	116,387,795

All prices are delayed by at least 15 minutes. Share Compare cannot be held responsible for the accuracy of share prices shown on this website, and investors should be aware that share prices can go down as well as up. Share Compare does not offer advice, and is not regulated by the Financial Conduct Authority.